Sanofi
Global
About Us
About Us
At a glance
Our journey through time
Making in India
Sanofi India Leadership Team
Chasing Miracles of Science
Chasing Miracles of Science
Protecting with vaccines
Solutions in Diabetes
Fighting rare diseases
Dare to Know Epilepsy
Transforming lives with transplantation
Our Science
Our Science
Clinical Trials & Results
Clinical Trials & Results
Multiple Sclerosis
Pharmaceutical products
Vaccines
Specialty Care Products
For healthcare professionals
Social Impact
Social Impact
Access to health
Engaged communities
Environmental impact
Ethics & transparency
Consumer Healthcare
Consumer Healthcare
Health & well-being
Consumer Healthcare Products
Consumer Healthcare Products
All Products
Dulcoflex® - Constipation Relief Brand
For healthcare professionals
Investors
Investors
Our Business
Board of Directors and Leadership Team
Financial Results
Annual Reports
AGM
Investor Information
Disclosures Under Reg-46 of the Listing Regulations
CSR
Shareholder Corner
Scheme of Arrangement
Media
Media
Media Release
Media
Media
Press Releases
Company statements
Investors
Investors
Board of Directors and Leadership Team
Board of Directors and Leadership Team
Board of Directors
Directorships and full-time positions
Board Committees
Sanofi India Limited Leadership Team
Financial Results
Annual Reports
AGM
Scheme of Arrangement
Investor Information
Investor Information
Shareholding pattern
Corporate Governance
Analyst / Investor Meet
Postal Ballot
Secretarial Compliance Report
Related Party Disclosures
Annual Return
Stock Exchange Announcement and Disclosures
Newspaper Advertisement
Disclosures Under Reg. 46 of the Listing Regulations
Disclosures Under Reg. 46 of the Listing Regulations
Our Business
Letter of Appointment of Independent Directors
Composition of Board Committee
Code of Conduct and Policies
Familiarization Programme
Contact information for grievance redressal
Notice of Board Meeting
Financial results
Annual Reports
Shareholding Pattern
Analyst Meet
Notice given to shareholders by way advertisement
Audited Financial Results of Subsidiary
Secretarial Compliance Report
Policy for Determination of Materiality
KMP authorized for Determination of Materiality
Disclosures under Reg. 30 of the Listing Regulations
Memorandum and Articles of Association
Annual Return
CSR
Shareholder’s Corner
Shareholder’s Corner
Unclaimed Dividends
Unpaid Dividends
Unclaimed shares
Investor services
Contact Us
Careers
Careers
Working at Sanofi
Hyderabad Hub
Contact Us
India
Investors
Disclosures Under Reg. 46 of the Listing Regulations
Code of Conduct and Policies
Code of Conduct and Policies
Code of Conduct and Policies
Material Subsidiary Policy (PDF)
Policy for Determination of Materiality for disclosure of events or information to Stock Exchanges (PDF)
Contact details for the Key Managerial Personnel authorized for determining materiality of an event or information as per Reg. 30 of SEBI LODR (PDF)
HSE Policy (PDF)
Familiarization program for independent directors 2022 (PDF • August 30 2022)
Risk Management Policy (PDF • August 30 2022)
Prevention of Sexual Harrasment (POSH) (PDF • August 30 2022)
Policy on diversity of Board of Directors (PDF • August 30 2022)
Familiarization Program for Independent Directors (PDF • October 26 2021)
Related party Transaction Policy (PDF • April 01, 2019)
Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI) (PDF • April 01, 2019)
Nomination and Remuneration Policy (PDF • March 08, 2019)
Corporate Social Responsibility Policy (PDF • February 26, 2019)
Terms and Conditions of Appointment of Independent Directors of Sanofi India Limited (PDF • November 23, 2018)
Whistle Blower Policy (PDF • January 04, 2017)
Dividend Distribution Policy (PDF • November 16, 2016)
Policy for Preservation of Documents (PDF • April 01, 2016)
Policy for retention of content and archival on website of the company (PDF • February 05, 2016)
Code of Business Conduct and Ethics for Directors and Sr. Management (PDF • July 24, 2014)
